Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative pain and negative affect after thoracic surgery (ChiCTR2500104325)
ChiCTR2500104325Phase 4Recruiting
- Sponsor
- Hefei Second People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain and Negative affective states (NAS) (4 arms), sponsored by Hefei Second People's Hospital. Primary endpoint: Incidence of moderate-to-severe postoperative pain within 48 hours after surgery. Started Jun 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painNegative affective states (NAS)
Beyond the preview
Go deeper on ChiCTR2500104325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104325.